SEC Form 4 · accession 0000899243-16-032641
MyoKardia Inc · MYOK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Anastasios Gianakakos
Officer — President and CEO · Director
Period of report
Oct 31, 2016
Accepted (ET)
Nov 2, 2016 · 5:40 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001552451
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Oct 31, 2016 | A | 898 | $10.03 | A | 508,254 | D | |
| Common StockF2 | holding | — | — | — | 181,169 | I | Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | $1.51 | Nov 1, 2016 | A | 27,891 | A | Nov 1, 2016 | Jun 3, 2025 | Common Stock | 27,891 | 27,891 | D |
Explanation of responses
- F1Shares acquired pursuant to the Issuer's 2015 Employee Stock Purchase Plan.
- F2On October 10, 2016, the Tassos Gianakakos 2015 Annuity Trust, dated September 25, 2015 (the "Trust") transferred 22,912 shares to the Reporting Person. The Reporting Person as trustee has sole dispositive power over the shares held in the Trust.
- F3On June 4, 2015, the Reporting Person was granted an option to purchase 111,565 shares of Common Stock under the issuer's 2012 Equity Incentive Plan, the vesting of which was subject to various conditions (other than the passage of time and continued employment) that were not tied to the market price of the issuer's securities. On November 1, 2016, one of the conditions was deemed to be achieved, resulting in the vesting and exercisability of 27,891 of the shares underlying such option.